Taken together, our results suggested that NS1 downregulated the NLRP3 inflammasome by targeting NF-κB and NLRP3, which may benefit in vivo virus infection by acting as an immune evasion strategy. This evidence concerns the gene NLRP3 and viral infectious disease.